This week, the FDA paused the use of Johnson & Johnson's COVID-19 vaccine because of reports of six women under 50 who developed a rare form of blood clots called cerebral venous sinus thrombosis. Today, Stephanie Desmon talks with Dr. Josh Sharfstein about what this means for vaccine rollouts, vaccine hesitancy, and what might happen next. This bonus episode has been lifted from yesterday's Facebook live which can be seen at www.facebook.com/JohnsHopkinsSPH/.
